Author
Bao-Cai Xing
Also Known As
B -C Xing, B C Xing, B Xing, Bao-Cai Xing, Bao-cai Xing, Baocai Xing, Baojian Xing, Beibei Xing, Xing, Bohao
50
Publications
1.9K
Citations
14
H-Index
23
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 5 | 5 | 1.6K |
2 | Hepatology | 4 | 4 | 1.5K |
3 | Health Sciences | 2 | 2 | 91 |
4 | Gastroenterology | 1 | 1 | 18 |
5 | Immunology | 1 | 1 | 25 |
Bao-Cai Xing
×
15
Publications
1.8K
Citations
13
H-Index
| Year | Citations | |
|---|---|---|
2021 | 1K | |
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Shukui Qin, Minshan Chen, Ann‐Lii Cheng, Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma | 2023 | 415 |
2013 | 66 | |
2016 | 57 | |
2018 | 53 | |
2021 | 44 | |
2011 | 25 | |
2021 | 25 | |
2025 | 25 | |
2020 | 19 |
Page 1
Page 1